Tiziana Life Sciences Identifies New Immune Biomarkers in Multiple Sclerosis Patients Treated with Foralumab
Shots: Tiziana identified new immune biomarkers in na-SPMS patients treated with n...
Shots: Tiziana identified new immune biomarkers in na-SPMS patients treated with n...
Shots: Silexion reported preclinical data of SIL-204 (siRNA agent) + 5-fluorouraci...
Shots: Light Horse has entered into a multi-target partnership with Novartis to di...
Shots: Atavistik Bio has signed a research collaboration with Pfizer to discover n...
Shots: Axcelead Drug Discovery Partners and Astellas have signed a drug discovery...
Shots: Kind highlighted the preclinical data of AND017 in Townes SCD, inducible Mu...
Incisive News in 3 Shots.
Modal body text goes here.